Global Rats Model Services Market Size By Type (Outbred, Inbred), By Application (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies), By Region, And Segment Forecasts, 2023...

The Global Rats Model Services Market was valued at USD 495 million in 2023 and is projected to reach USD 902 million by 2031, expanding at a CAGR of 7.6% during the forecast period from 2023 to 2031. This growth is driven by rising investments in preclinical research, increasing reliance on rats for drug development studies, and expanding use of rat models in genetic, oncology, and neurological research. Rat models are preferred in pharmaceutical and biotechnology industries due to their close genetic, biological, and behavioral similarities to humans, making them ideal for studying disease progression and treatment response.

Drivers:

1. Surge in Preclinical and Toxicological Research:

Pharmaceutical and biotech firms increasingly utilize rats for toxicology testing and pharmacokinetics studies, boosting the demand for rat model services.

2. Advancements in Genetic Engineering:

CRISPR and other gene-editing technologies have enhanced the ability to develop precise rat models for human diseases, driving market expansion.

3. Rising Demand in Oncology and Neurology:

Rats serve as vital models for studying tumor biology and neurodegenerative conditions, supporting the development of novel therapeutics.

Restraints:

1. Ethical Concerns and Regulatory Hurdles:

Stringent animal welfare regulations and growing ethical scrutiny over animal testing can pose limitations on market growth.

2. High Costs and Complexity of Customized Models:

Developing and maintaining genetically modified rat models involve high costs and technical expertise, making services expensive for smaller research entities.

Opportunity:

1. Emerging Markets and Academic Research Institutions:

Expansion of contract research organizations (CROs) and rising R&D expenditure in countries like India, China, and Brazil offer lucrative growth prospects.

2. Integration of AI and Imaging Technologies:

Integration of advanced imaging and artificial intelligence in rat model research enables better disease tracking and data interpretation, fostering innovation in services.

Market by System Type Insights:

In 2023, the Genetically Engineered Rat Models segment held the largest share of the market. These models offer enhanced accuracy in mimicking human conditions, especially in immunology, metabolic disorders, and oncology. Surgical Models are expected to witness rapid growth due to their importance in cardiovascular and neuroscience studies, providing insights into physiological responses under controlled conditions.

Market by End-use Insights:

The Pharmaceutical and Biotechnology Companies segment dominated the market in 2023, driven by increased new drug discovery pipelines and demand for translational research. Meanwhile, Academic and Research Institutes are projected to experience significant growth, as governments and foundations fund preclinical studies and toxicology testing in rats.

Market by Regional Insights:

North America accounted for the largest market share in 2023, attributed to high R&D investments, presence of major CROs, and stringent but structured regulatory frameworks. However, Asia-Pacific is expected to grow at the fastest pace through 2031, with countries like China and India enhancing their preclinical research capacities and offering cost-effective rat model services.

Competitive Scenario:

Key players in the Global Rats Model Services Market include Charles River Laboratories, Envigo, Taconic Biosciences, Janvier Labs, GenOway, Horizon Discovery, Biomedical Research Models (BRM), Cyagen Biosciences, and TransGenic Inc. These companies focus on expanding service portfolios, strategic collaborations, and investments in advanced gene-editing technologies.

Scope of Work – Global Rats Model Services Market

Key Market Developments:

2023: Charles River Laboratories expanded its portfolio by introducing novel CRISPR-based rat models for oncology and immunology applications.

2024: Taconic Biosciences partnered with a leading Japanese research institute to develop customized rat models for neurodegenerative disease research.

2025: Cyagen Biosciences launched AI-integrated imaging analytics tools to support data-driven rat model studies in metabolic disorders.

FAQs:

1) What is the current market size of the Global Rats Model Services Market?

The market was valued at USD 495 million in 2023.

2) What is the major growth driver of the Global Rats Model Services Market?

The rising use of rat models in preclinical research, especially in drug discovery and disease modeling, is the primary growth driver.

3) Which is the largest region during the forecast period in the Global Rats Model Services Market?

North America leads the market, while Asia-Pacific is expected to witness the fastest growth.

4) Which segment accounted for the largest market share in the Global Rats Model Services Market?

Genetically Engineered Rat Models held the largest share in 2023.

5) Who are the key market players in the Global Rats Model Services Market?

Key players include Charles River Laboratories, Envigo, Taconic Biosciences, Janvier Labs, and GenOway.